Scythian Biosciences Corp (SCYB.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 09/30
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 366 | 19 | 369 | 80 | 864 |
| Receivables | 1,379 | 1,004 | 1,187 | 5,003 | 4,381 |
| TOTAL | $3,987 | $2,865 | $3,951 | $8,435 | $5,618 |
| Non-Current Assets | |||||
| PPE Net | 134 | 185 | 237 | 286 | 340 |
| Investments And Advances | 709 | 815 | 1,150 | 1,640 | 1,516 |
| Intangibles | 3,422 | 3,768 | 4,114 | 3,764 | 4,113 |
| Other Non-Current Assets | 3,334 | 3,351 | 3,520 | 76 | 76 |
| TOTAL | $7,600 | $8,120 | $9,021 | $5,765 | $6,044 |
| Total Assets | $11,587 | $10,985 | $12,971 | $14,199 | $11,662 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,641 | 60 | 60 | 60 | 60 |
| Accounts payable and accrued liabilities | 3,850 | 3,127 | 3,091 | N/A | N/A |
| Other current liabilities | N/A | N/A | N/A | N/A | 590 |
| TOTAL | $8,215 | $6,146 | $5,279 | $3,411 | $3,899 |
| Non-Current Liabilities | |||||
| Long Term Debt | 129 | 127 | 124 | 113 | 113 |
| Deferred Revenues | 1,457 | 362 | 541 | N/A | N/A |
| Other Non-Current Liabilities | 1,933 | 1,547 | 999 | -3,315 | -2,999 |
| TOTAL | $129 | $127 | $124 | $245 | $237 |
| Total Liabilities | $8,344 | $6,273 | $5,404 | $3,656 | $4,136 |
| Shareholders' Equity | |||||
| Common Shares | 55,111 | 54,052 | 53,434 | 54,001 | 50,703 |
| Retained earnings | -80,980 | -78,623 | -75,950 | -77,191 | -75,408 |
| Other shareholders' equity | 7,921 | 8,127 | 8,127 | 7,205 | 5,467 |
| TOTAL | $5,176 | $6,258 | $8,567 | $7,228 | $4,527 |
| Total Liabilities And Equity | $13,520 | $12,532 | $13,971 | $10,884 | $8,663 |